Anales de la RANM

72 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 ETIOPATOGENIA Y TRATAMIENTO DE LOS ABSCESOS HEPÁTICOS PIÓGENOS Jiménez Romero C, et al. An RANM. 2025;142(01): 61 - 72 44. Law ST, Li KK. Role of C-reactive protein in response-guided therapy of pyogenic li- ver abscess. Eur J Gastroenterol Hepatol. 2014;26:179–186. 45. Chen SC, Wu WY, Yeh CH, et al. Comparison of escherichia coli and klebsiella pneumoniae liver abscesses. Am J Med Sci. 2007;334:97– 105. 46. Lee CH, Jo HG, Cho EY, et al. Maximal dia- meter of liver abscess independently predicts prolonged hospitalization and poor prognosis in patients with pyogenic liver abscess. BMC Infect Dis. 2021;21:171. 47. Hsieh CH, Chen RJ, Fang JF, et al. Liver abscess after non-operative management of blunt liver injury. Langenbeck’s Arch Surg. 2003;387(9–10):343–347. 48. Hope WW, Vrochides D V., Newcomb WL, Mayo-Smith WW, Iannitti DA. Optimal treatment of hepatic abscess. Am Surg. 2008;74:178–182. 49. He S, Yu J, Wang H, Chen X, He Z, Chen Y. Percutaneous fine-needle aspiration for pyogenic liver abscess (3-6 cm): A two- center retrospective study. BMC Infect Dis. 2020;20:1–8. 50. Zerem E, Hadzic A. Sonographically gui- ded percutaneous catheter drainage ver- sus needle aspiration in the management of pyogenic liver abscess. Am J Roentgenol. 2007;189:138–142. Si desea citar nuestro artículo: Jiménez Romero C, Moreno González E, Lechuga Alonso I, Justo Alonso I. Etiopatogenia y tratamiento de los abscesos hepáticos piógenos en la población general y en trasplante hepático. An RANM. 2025;142(01): 61– 72. DOI: 10.32440/ar.2025.142.01. rev06